Managing  ||| S:0 E:9 ||| VBG
hyponatremia  ||| S:9 E:22 ||| NN
in  ||| S:22 E:25 ||| IN
cirrhosis  ||| S:25 E:35 ||| VBG
The  ||| S:35 E:39 ||| DT
development  ||| S:39 E:51 ||| NN
of  ||| S:51 E:54 ||| IN
hyponatremia  ||| S:54 E:67 ||| NN
represents  ||| S:67 E:78 ||| VBZ
an  ||| S:78 E:81 ||| DT
ominous  ||| S:81 E:89 ||| JJ
event  ||| S:89 E:95 ||| NN
in  ||| S:95 E:98 ||| IN
the  ||| S:98 E:102 ||| DT
progression  ||| S:102 E:114 ||| NN
of  ||| S:114 E:117 ||| IN
cirrhosis  ||| S:117 E:127 ||| VBG
to  ||| S:127 E:130 ||| TO
end-stage  ||| S:130 E:140 ||| JJ
liver  ||| S:140 E:146 ||| NN
disease ||| S:146 E:153 ||| NN
.  ||| S:153 E:155 ||| .
It  ||| S:155 E:158 ||| PRP
usually  ||| S:158 E:166 ||| RB
develops  ||| S:166 E:175 ||| VBZ
in  ||| S:175 E:178 ||| IN
those  ||| S:178 E:184 ||| DT
with  ||| S:184 E:189 ||| IN
refractory  ||| S:189 E:200 ||| JJ
ascites  ||| S:200 E:208 ||| NN
and  ||| S:208 E:212 ||| CC
is  ||| S:212 E:215 ||| VBZ
a  ||| S:215 E:217 ||| DT
manifestation  ||| S:217 E:231 ||| NN
of  ||| S:231 E:234 ||| IN
the  ||| S:234 E:238 ||| DT
non-osmotic  ||| S:238 E:250 ||| JJ
release  ||| S:250 E:258 ||| NN
of  ||| S:258 E:261 ||| IN
arginine  ||| S:261 E:270 ||| JJ
vasopressin  ||| S:270 E:282 ||| NNS
( ||| S:282 E:283 ||| -LRB-
AVP ||| S:283 E:286 ||| NNP
) ||| S:286 E:287 ||| -RRB-
.  ||| S:287 E:289 ||| .
In  ||| S:289 E:292 ||| IN
the  ||| S:292 E:296 ||| DT
hospitalized  ||| S:296 E:309 ||| JJ
cirrhotic  ||| S:309 E:319 ||| JJ
patient ||| S:319 E:326 ||| NN
,  ||| S:326 E:328 ||| ,
hyponatremia  ||| S:328 E:341 ||| NN
is  ||| S:341 E:344 ||| VBZ
associated  ||| S:344 E:355 ||| VBN
with  ||| S:355 E:360 ||| IN
increased  ||| S:360 E:370 ||| JJ
disease  ||| S:370 E:378 ||| NN
severity  ||| S:378 E:387 ||| NN
and  ||| S:387 E:391 ||| CC
mortality ||| S:391 E:400 ||| NN
.  ||| S:400 E:402 ||| .
In  ||| S:402 E:405 ||| IN
this  ||| S:405 E:410 ||| DT
article ||| S:410 E:417 ||| NN
,  ||| S:417 E:419 ||| ,
we  ||| S:419 E:422 ||| PRP
review  ||| S:422 E:429 ||| VB
the  ||| S:429 E:433 ||| DT
pathophysiology  ||| S:433 E:449 ||| NN
of  ||| S:449 E:452 ||| IN
hyponatremia ||| S:452 E:464 ||| NN
,  ||| S:464 E:466 ||| ,
its  ||| S:466 E:470 ||| PRP$
clinical  ||| S:470 E:479 ||| JJ
implications ||| S:479 E:491 ||| NNS
,  ||| S:491 E:493 ||| ,
evaluation ||| S:493 E:503 ||| NN
,  ||| S:503 E:505 ||| ,
and  ||| S:505 E:509 ||| CC
treatment ||| S:509 E:518 ||| NN
.  ||| S:518 E:520 ||| .
